High Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 Ticagrelor

China High Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 Ticagrelor, Find details about China Ticagrelor, 274693-27-5 from High Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 Ticagrelor

Model NO.
Ticagrelor
Mf
C23h28f2n6o4s
MW
522.57
CAS
274693-27-5
Appearance
White Crystalline Powder
Function
Biological and Pharmaceutical Intermediates
Shelf Life
2 Years
Test Method
HPLC UV
Storage
Cool Dry Place
Payment
Tt.Western Union .Credit Card.Moneygram
Delivery Time
Within 2 Days
Certificate
COA MSDS
Sample
Available
Trademark
Faithful
Transport Package
Aluminum Foil Bag Packaging
Specification
10g/bag; 100g/bag; 1kg/bag
Origin
China
Model NO.
Ticagrelor
Mf
C23h28f2n6o4s
MW
522.57
CAS
274693-27-5
Appearance
White Crystalline Powder
Function
Biological and Pharmaceutical Intermediates
Shelf Life
2 Years
Test Method
HPLC UV
Storage
Cool Dry Place
Payment
Tt.Western Union .Credit Card.Moneygram
Delivery Time
Within 2 Days
Certificate
COA MSDS
Sample
Available
Trademark
Faithful
Transport Package
Aluminum Foil Bag Packaging
Specification
10g/bag; 100g/bag; 1kg/bag
Origin
China
High Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 TicagrelorHigh Purity Sodium cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 Ticagrelor

Introduction

Molecular FormulaC23H28F2N6O4S
Boiling point777.6±70.0 °C
Density1.67
Molecular weight522.57

Function

Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world's first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.
It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.

Application

Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS)

Specification
 

Tests

 

Specification

 

Results

 

Identification

 

Musculine reaction

 

Conform

 

Description

 

White powder

 

Conform

 

Clarity and Color

 

Should conform

 

Conform

 

Specific rotation

-92°~-109°

-97.5°

 

Other Impurities

0.5%

0.16%

 

Loss on drying

3.0%

2.0%

 

Limit of(R)-olfx

1.0%

0.45%

 

Residue on ignition

0.2%

0.05%

 

Heavy metals

0.002%

Conform

 

Assay

98.5%

99.0%

 

 

High Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 TicagrelorHigh Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 TicagrelorHigh Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 TicagrelorHigh Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 TicagrelorHigh Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 TicagrelorHigh Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 TicagrelorHigh Purity Sodium Cromoglycate/Cromolyn Disodium 15826-37-6 Cromolyn Sodium//Hypoxanthine 68-94-0//6-Chloropurine 87-42-3//274693-27-5 Ticagrelor